STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Ainos Director Reports 50,000-Share Special Stock Award on Form 4

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ainos, Inc. (AIMD) reported an insider equity transaction by a director. On 11/25/2025, the reporting person received 50,000 shares of common stock as special stock awards at a reported price of $2.10 per share, increasing their directly held stake to 90,880 shares after the transaction. These 50,000 shares were granted and vested as part of special stock awards that had been approved by Ainos stockholders on 11/7/2025. The filing also shows related movements in restricted stock units and their conversion into common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
tsai chung-yi

(Last) (First) (Middle)
8880 RIO SAN DIEGO DRIVE
SUITE 800

(Street)
SAN DIEGO CA 92108

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ainos, Inc. [ AIMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 11/25/2025 A 50,000(1) A $2.1 90,880 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
RSU (1) 11/25/2025 A 50,000 (1) (1) Common Stock 50,000 (1) 0 D
RSU (1) 11/25/2025 C 50,000 (1) (1) Common Stock 50,000 (1) 0 D
Explanation of Responses:
1. Reference is made to the 50,000 shares of common stock granted and vested to the Reporting Person as special stock awards on November 25, 2025. The special stock awards have been approved by the stockholders of Ainos, Inc. on November 7, 2025.
/s/ Chun-Hsien Tsai by POA for Chung-Yi Tsai 11/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Ainos, Inc. (AIMD) report in this Form 4?

Ainos, Inc. reported that a director acquired 50,000 shares of common stock on 11/25/2025 through special stock awards that were granted and vested on that date.

At what price were the 50,000 Ainos (AIMD) shares reported in the Form 4?

The 50,000 shares of Ainos common stock were reported at a price of $2.10 per share in the Form 4.

How many Ainos (AIMD) shares does the reporting person own after this transaction?

Following the reported transaction, the director beneficially owns 90,880 shares of Ainos, Inc. common stock, held as direct ownership.

What is the nature of the 50,000-share award reported for Ainos (AIMD)?

The 50,000 shares are described as special stock awards that were granted and vested to the reporting person on 11/25/2025 and were approved by Ainos stockholders on 11/7/2025.

Does this Ainos (AIMD) Form 4 involve derivative securities like RSUs?

Yes. Table II shows 50,000 restricted stock units (RSUs) acquired on 11/25/2025 and a corresponding 50,000 RSU conversion into common stock, leaving 0 derivative securities beneficially owned afterward.

What is the relationship of the reporting person to Ainos, Inc. (AIMD)?

The reporting person is identified as a Director of Ainos, Inc., and the Form 4 is filed for one reporting person with direct ownership of the reported shares.
Ainos Inc

NASDAQ:AIMD

AIMD Rankings

AIMD Latest News

AIMD Latest SEC Filings

AIMD Stock Data

10.15M
1.66M
56.73%
0.13%
2.59%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO